5-Hydroxytryptamine dominates over thromboxane A2 in reducing collateral blood flow by activated platelets

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Hemostasis

Background:

• Collagen infusion in feline hindlimbs causes platelet activation, reduced blood flow, and increased vascular resistance.
• These effects are more pronounced in collateral arterial beds compared to normal ones.

Purpose of the Study:

• To investigate the roles of serotonin (5-HT) and thromboxane A2 (TxA2) in collagen-induced hemodynamic changes in feline hindlimb collateral circulation.
• To determine which mediator, 5-HT or TxA2, plays a dominant role in reducing blood flow in collateral-dependent tissues.

Main Methods:

• Intra-aortic collagen infusion in feline hindlimbs.
• Pharmacological blockade of 5-HT2 receptors (ketanserin, ritanserin) or amine depletion (reserpine, parachlorophenylalanine).
• Inhibition of cyclooxygenase (indomethacin), TxA2/prostaglandin endoperoxide receptor antagonism (sulotroban), or TxA2 synthase inhibition (dazoxiben, ridogrel).
• Measurement of blood flow, vascular resistance, platelet activation, and mediator release (5-hydroxyindoles, TxB2, prostacyclin).

Main Results:

• Blockade of 5-HT2 receptors or amine depletion largely prevented collagen-induced perfusion defects without significantly affecting platelet activation.
• Cyclooxygenase inhibition or TxA2/prostaglandin endoperoxide receptor antagonism did not prevent the perfusion defect.
• TxA2 synthase inhibition partially reduced the perfusion defect and mediator release, while increasing prostacyclin levels.

Conclusions:

• Platelet-derived serotonin (5-HT) is the primary mediator responsible for reducing blood flow in collateral-dependent feline hindlimb tissue following collagen infusion.
• Serotonin's effect on blood flow in this model is more significant than that of thromboxane A2.
• Targeting 5-HT pathways may be a therapeutic strategy for improving blood flow in collateral-dependent tissues.